1.
Ariyawongsakul S, jantrasoontragul winyoo, Tiratuntayaporn R, Nijwattana C. A Proof-of-Concept Study for an Intradermal Dose-Sparing Strategy: Non-Inferior Immunogenicity and Improved Systemic Tolerability of Fractional-Dose ChAdOx1-S SARS-CoV-2 Vaccine Compared to Intramuscular Administration. rtafmg [internet]. 2025 Dec. 29 [cited 2026 Sep. 18];71(2):106-17. available from: https://he02.tci-thaijo.org/index.php/rtafmg/article/view/278771